HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frederick L Ferris Selected Research

Geographic Atrophy

1/2019Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39.
1/2017Visual and Morphologic Outcomes in Eyes with Hard Exudate in the Comparison of Age-Related Macular Degeneration Treatments Trials.
9/2015Image Scaling Difference Between a Confocal Scanning Laser Ophthalmoscope and a Flash Fundus Camera.
12/2014Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trial.
2/2014Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
4/2013Treatment of geographic atrophy with subconjunctival sirolimus: results of a phase I/II clinical trial.
2/2011Changes in retinal sensitivity in geographic atrophy progression as measured by microperimetry.
12/2010Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial.
11/2008The HtrA1 promoter polymorphism, smoking, and age-related macular degeneration in multiple case-control samples.
9/2008The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frederick L Ferris Research Topics

Disease

27Macular Degeneration (Age-Related Maculopathy)
01/2020 - 11/2003
21Macular Edema
01/2022 - 11/2005
18Diabetic Retinopathy (Retinopathy, Diabetic)
10/2018 - 09/2003
17Eye Diseases (Eye Disease)
01/2020 - 06/2003
16Cataract (Cataracts)
04/2016 - 09/2003
14Geographic Atrophy
01/2019 - 04/2005
6Endophthalmitis (Ophthalmia)
01/2016 - 06/2010
3Disease Progression
01/2022 - 11/2009
2Graft vs Host Disease (Graft-Versus-Host Disease)
08/2021 - 01/2021
2Cardiovascular Diseases (Cardiovascular Disease)
12/2015 - 11/2012
2Choroidal Neovascularization
02/2015 - 04/2005
2Retinal Detachment (Retinal Detachments)
11/2005 - 04/2005
2Hemorrhage
11/2005 - 04/2005
2Diabetes Complications
03/2005 - 09/2004
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
03/2005 - 09/2004
1Genetic Risk Score
01/2020
1Atrophy
01/2020
1Cicatrix (Scar)
01/2017
1Retinitis Pigmentosa (Pigmentary Retinopathy)
06/2016
1Stroke (Strokes)
12/2015
1Heart Diseases (Heart Disease)
12/2015
1Hypertension (High Blood Pressure)
12/2015
1Retinal Neovascularization
11/2015
1Sarcoidosis (Schaumann Disease)
07/2014
1Lung Neoplasms (Lung Cancer)
02/2014
1Epiretinal Membrane (Epiretinal Membranes)
10/2010
1Neoplasms (Cancer)
02/2007
1von Hippel-Lindau Disease (von Hippel Lindau Disease)
02/2007

Drug/Important Bio-Agent (IBA)

18Retinaldehyde (Retinal)IBA
02/2017 - 11/2003
17Ranibizumab (Lucentis)FDA Link
01/2020 - 11/2008
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 02/2007
9AntioxidantsIBA
03/2014 - 06/2003
8Bevacizumab (Avastin)FDA Link
01/2022 - 07/2012
8LuteinIBA
07/2015 - 12/2006
6ZeaxanthinsIBA
07/2015 - 09/2007
5afliberceptIBA
01/2022 - 03/2015
5VitaminsIBA
03/2014 - 11/2008
4Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2015
4Triamcinolone (Aristocort)FDA Link
04/2016 - 06/2010
4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
12/2015 - 09/2003
4Complement Factor H (Factor H)IBA
07/2014 - 04/2005
4ZincIBA
02/2014 - 06/2003
4Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
07/2013 - 09/2008
4CholesterolIBA
11/2012 - 09/2004
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2016 - 11/2012
3LipidsIBA
05/2007 - 11/2003
2Pharmaceutical PreparationsIBA
02/2016 - 06/2012
2Anti-Bacterial Agents (Antibiotics)IBA
01/2016 - 06/2012
2Sirolimus (Rapamycin)FDA Link
12/2014 - 04/2013
2Ascorbic Acid (Vitamin C)FDA LinkGeneric
02/2014 - 09/2007
2Vitamin EFDA LinkGeneric
02/2014 - 01/2006
2Fluorescein (Funduscein)FDA LinkGeneric
03/2010 - 02/2007
2alpha-TocopherolFDA Link
09/2007 - 01/2006
2Carotenoids (Carotene)IBA
09/2007 - 12/2006
2CreatinineIBA
11/2005 - 09/2004
2Hemoglobin AIBA
11/2005 - 09/2004
1NucleotidesIBA
01/2020
1CalciumIBA
01/2019
1Dietary CalciumIBA
01/2019
1Vascular Endothelial Growth FactorsIBA
01/2017
1Valproic Acid (Depakote)FDA LinkGeneric
06/2016
1Molecular Chaperones (Chaperone, Molecular)IBA
02/2016
1Crystallins (Crystallin)IBA
02/2016
1Proteins (Proteins, Gene)FDA Link
02/2016
1Niacin (Nicotinic Acid)FDA LinkGeneric
07/2015
1Folic Acid (Vitamin M)FDA LinkGeneric
07/2015
1Riboflavin (Vitamin B2)FDA LinkGeneric
07/2015
1Vitamin B Complex (B Vitamins)IBA
07/2015
1AutoantibodiesIBA
12/2014
1Interleukin-17 (Interleukin 17)IBA
07/2014
1beta Carotene (Betacarotene)FDA Link
02/2014
1CopperIBA
02/2014
1Green OrIBA
11/2013
1Immunosuppressive Agents (Immunosuppressants)IBA
04/2013
1salicylhydroxamic acid (SHAM)IBA
06/2011
1Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
06/2011
1SteroidsIBA
05/2011
1Hydroxylamine (Hydroxylamine Hydrochloride)IBA
12/2010
1OT-551IBA
12/2010
1Adrenal Cortex Hormones (Corticosteroids)IBA
08/2010
17,14-dihydroxypregn-4-ene-3,20-dioneIBA
03/2010
1Celecoxib (Celebrex)FDA Link
03/2010
1Toll-Like Receptors (Toll-Like Receptor)IBA
12/2009
1MineralsIBA
01/2009
1No. 407IBA
01/2009
1alpha-Crystallins (alpha-Crystallin)IBA
12/2008
1Monoclonal AntibodiesIBA
11/2008
1Vitamin A (Retinol)FDA LinkGeneric
09/2007
1pegaptanib (Macugen)FDA Link
02/2007

Therapy/Procedure

11Lasers (Laser)
04/2016 - 09/2003
10Light Coagulation
10/2018 - 09/2003
7Therapeutics
01/2022 - 03/2005
5Injections
02/2017 - 08/2010
3Vitrectomy
11/2015 - 09/2003
2Slit Lamp
02/2016 - 11/2010
1Lenses
02/2016
1Retreatment
01/2016
1Estrogen Replacement Therapy
11/2011
1Topical Administration
12/2010
1Intravitreal Injections
11/2008